Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients
1 other identifier
interventional
8,287
1 country
1
Brief Summary
This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedFirst Submitted
Initial submission to the registry
October 25, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedOctober 27, 2021
October 1, 2021
2 months
October 25, 2021
October 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Days to COVID-19 vaccination
Days to COVID-19 vaccination
During the 8 weeks after Study Outreach 1 was sent
Study Arms (3)
Standard PCP Outreach
EXPERIMENTALThese patients were sent standard outreach messages to promote COVID-19 vaccination.
Culturally Tailored PCP Outreach
EXPERIMENTALThese patients were sent messages similar to those in the Standard PCP Outreach Group, but with additional culturally tailored content.
Usual Care
NO INTERVENTIONThese patients were not sent the above study outreach messages, but may have received other messages from their local medical centers or counties.
Interventions
These patients were sent two study outreach messages. Study Outreach 1 was an electronic secure message sent on behalf of the PCP, encouraging COVID-19 vaccination and designed based on behavioral science principles. Letters were sent to patients who had not signed up for the electronic health record portal. Study Outreach 2 was a postcard sent to all patients who had not been vaccinated or made an appointment by four weeks after Study Outreach 1.
These patients were sent messages similar to those in Standard PCP Outreach, but with additional culturally tailored content and photos.
Eligibility Criteria
You may not qualify if:
- Received COVID-19 vaccine prior to Study Outreach 1.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaiser Permanente Northern California
Oakland, California, 94612, United States
Related Publications (1)
Lieu TA, Elkin EP, Escobar PR, Finn L, Klein NP, Durojaiye C, Prausnitz S, Quesenberry CP, Sawyer D, Teran S, Goler N, Parodi SM, Chen YI. Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination of Black and Latino Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jun 1;5(6):e2217004. doi: 10.1001/jamanetworkopen.2022.17004.
PMID: 35713906DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Tracy Lieu, MD
The Permanente Medical Group
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Telephone interviewers were blind to study group assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2021
First Posted
October 27, 2021
Study Start
March 29, 2021
Primary Completion
May 20, 2021
Study Completion
August 31, 2021
Last Updated
October 27, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- December 1, 2022 through December 1, 2024
- Access Criteria
- Deidentified data will be shared on submission of a protocol approved by the Kaiser Permanente Northern California Institutional Review Board or Research Determination Official, and contingent on appropriate data sharing agreement being completed.
Deidentified data will be shared on submission of a protocol approved by the Kaiser Permanente Northern California Institutional Review Board or Research Determination Official, and contingent on appropriate data sharing agreement being completed.